NEW YORK, April 3, 2015 /PRNewswire/ --
Auspex Pharmaceuticals, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Auspex Pharmaceuticals, Inc. ("ASPX") to Teva Pharmaceutical
Industries Ltd. in a cash transaction valued at approximately
$3.5 billion or $101.00 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
BioScrip, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties by the board of BioScrip, Inc.
("BIOS"). On March 31, 2015, a
federal judge denied, in part, a motion to dismiss a complaint
alleging that BIOS had made misleading statements pertaining to (i)
the distribution of the Novartis Pharmaceutical Corporation's
product Exjade® by BIOS' May 2012
divested legacy specialty pharmacy division; and (ii) BIOS' PBM
Services segment.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Catamaran Corporation
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Catamaran Corporation ("CTRX") to OptumRx in a transaction
valued at $61.50 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Cellular Dynamics International, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Cellular Dynamics International, Inc. ("ICEL") to FUJIFILM
Holdings Corporation in a transaction valued at $307 million or $16.50 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
First Security Group, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of First Security Group, Inc. ("FSGI") to Atlantic Capital
Bancshares, Inc. in a transaction valued at $160 million or $2.35 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Hyperion Therapeutics, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Hyperion Therapeutics, Inc. to Horizon Pharma plc in a
transaction valued at $1.1 billion or
$46.00 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
Norcraft Companies, Inc.
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of Norcraft Companies, Inc. ("NCFT") to Fortune Brands Home &
Security, Inc. in a transaction valued at $600 million or $25.50 per share.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2015 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)
493-9780. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-auspex-pharmaceuticals-inc-bioscrip-inc-catamaran-corporation-cellular-dynamics-international-inc-first-security-group-inc-hyperion-therapeutics-inc-and-norcraf-300060975.html
SOURCE Lifshitz & Miller Law Firm
